Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
Clinical trial NCT05533632 · COMPLETED
Trial details
- NCT number
- NCT05533632
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-25
- Primary completion
- 2024-01-18
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.